When looking for the best stocks to buy and watch, focus on those with rising relative price strength.
One stock that fits that bill is CRISPR Therapeutics, which had its Relative Strength (RS) Rating upgraded from 78 to 88 Friday. See Allison Gatlin's full report on the news reported yesterday.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
This unique rating tracks market leadership by showing how a stock's price movement over the last 52 weeks measures up against that of other stocks on the major indexes.
Over 100 years of market history shows that the market's biggest winners tend to have an 80 or better RS Rating in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
CRISPR Therapeutics is building a cup without handle with a 72.00 entry. See if the stock can break out in volume at least 40% above average.
CRISPR Therapeutics showed 0% EPS growth in the latest quarterly report. Revenue rose -100%.
The company earns the No. 20 rank among its peers in the Medical-Biomed/Biotech industry group. Neurocrine Biosciences and Immunogen are also among the group's highest-rated stocks.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
